Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$436K Sell
3,844
-391
-9% -$38.8K 0.01% 400
2026
Q1
$399K Sell
4,235
-1,398
-25% -$139K 0.01% 375
2025
Q4
$556K Sell
5,633
-373
-6% -$36.1K 0.02% 281
2025
Q3
$518K Sell
6,006
-1,067
-15% -$84.3K 0.01% 287
2025
Q2
$482K Sell
7,073
-983
-12% -$62.3K 0.02% 271
2025
Q1
$488K Buy
8,056
+166
+2% +$11.6K 0.02% 255
2024
Q4
$545K Buy
7,890
+650
+9% +$46.3K 0.02% 221
2024
Q3
$479K Buy
7,240
+562
+8% +$35.8K 0.02% 239
2024
Q2
$405K Buy
6,678
+1,062
+19% +$60.1K 0.02% 247
2024
Q1
$320K Buy
+5,616
New +$337K 0.01% 287
2020
Q1
Sell
-400
Closed -$30.8K 774
2019
Q4
$30.8K Buy
400
+382
+2,122% +$32.6K 0.01% 345
2019
Q3
$1.34K Buy
+18
New +$1.46K ﹤0.01% 699
2019
Q2
Sell
-15
Closed -$1.23K 365
2019
Q1
$1.23K Buy
+15
New +$1.22K ﹤0.01% 580

Other funds holding INCY

Advisory Alpha's INCY Position: Q2 2026 in Review

Advisory Alpha reduced its Incyte (INCY) stake by 9.2% in Q2 2026, selling an estimated $38.8K and leaving 3,844 shares worth $436K. The position accounts for 0.01% of the portfolio, ranked #400.

Advisory Alpha first reported a position in INCY in Q1 2019 and has held it in 13 quarters since. The position peaked at $556K in Q4 2025. 858 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Advisory Alpha held 3,844 shares of Incyte worth $436K as of Q2 2026.
  • Advisory Alpha sold 391 Incyte shares in Q2 2026, an estimated $38.8K.
  • Incyte made up 0.01% of Advisory Alpha's portfolio in Q2 2026, its #400 holding.
  • Advisory Alpha first reported a position in Incyte in Q1 2019 and has held it in 13 quarters since.
  • Advisory Alpha's Incyte position peaked at $556K in Q4 2025.
  • 858 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Advisory Alpha's 13F filing for Q2 2026, filed 11 Aug 2026.